KDKRW Kodiak AI lays out longterm AI commercialization plans alongside its latest quarterly earnings release PCSA Processa Pharmaceuticals posts worsethanexpected Q4 2025 EPS results that miss estimates by 68 percent as shares edge 033 percent lower INGN Inogen posts narrower than expected Q4 2025 loss stock registers mild gain in daily trading